More than 90% of dermatology clinicians surveyed by Leo Pharma say their patients with moderate to severe chronic hand eczema ...

Alongside this presentation, new systemic exposure data has also been shared for delgocitinib cream at the meeting. 2 “The data unveiled today further contributes to LEO Pharma’s ever-growing ...

In good news for patients living with chronic hand eczema (CHE), Leo Pharma – a company working ... topline results for its delgocitinib cream treatment, an investigational topical pan-Janus ...

Dermatology specialist LEO Pharma has built the case for its first ... for the condition in a phase 3 trial. LEO’s topical cream formulation of the pan-JAK inhibitor proved to be more effective ...